Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients

NCT01216124 · clinicaltrials.gov ↗

AVAILABLE

Status

OTHER

Sponsor class

Conditions

Triple Negative Local Advanced Breast Cancer

Interventions

DRUG: docetaxel oxaliplatin

Sponsor

Fudan University

Collaborators

[object Object]